Trials / Completed
CompletedNCT04654455
Prospective Study Evaluating Dry Eye in Patients Operated on for Ametropia by LASIK Surgery and Treated With REPADROP
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
LASIK is a refractive surgery technique widely used in France. Postoperatively, the classic treatment after LASIK consists of instilling drops to reduce dry eyes. REPADROP® is an innovative eye drops stimulating corneal innervation. To date no study has quantified the improvement in dry eye syndrome and thus the quality of life of patients using REPADROP®.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Describe the evolution of dry eye between 1 month and 3 months post-LASIK | Dry eye will be assessed through the OSDI (Ocular Surface Disease Index) questionnaire. The questionnaire will be dispensed during consultations by an orthoptist or an intern/junior doctor, at 1 month and at 3 months post-LASIK. |
Timeline
- Start date
- 2021-03-09
- Primary completion
- 2021-11-02
- Completion
- 2021-11-02
- First posted
- 2020-12-04
- Last updated
- 2021-12-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04654455. Inclusion in this directory is not an endorsement.